Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cue Biopharma, Inc. | 24,400 | reported | 02 Jan 2026 | tx 7+397,057 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Cue Biopharma, Inc. | 24,400 | 0.00 USD | deriv |
| 30 Dec 2025 | PURCHASE | Cue Biopharma, Inc. | 77,417 | 0.30 USD | |
| 30 Dec 2025 | PURCHASE | Cue Biopharma, Inc. | 86,947 | 0.32 USD | |
| 30 Dec 2025 | PURCHASE | Cue Biopharma, Inc. | 77,148 | 0.30 USD | |
| 30 Dec 2025 | PURCHASE | Cue Biopharma, Inc. | 4,229 | 0.31 USD | |
| 30 Dec 2025 | PURCHASE | Cue Biopharma, Inc. | 78,116 | 0.31 USD | |
| 10 Mar 2025 | GRANT_AWARD | Cue Biopharma, Inc. | 48,800 | 0.00 USD | deriv |